User access denied after restriction

Learn why user access is denied after pharmacy restrictions and how independent pharmacists adapt to new wellness services.

Isatuximab approval in the EU marks the first subcutaneous Sarclisa delivery via the CirCLIQ injector, expanding multiple myeloma…

New drugs take time to get insurance reimbursement, with little change over the past decade in the US…

Medicare payment models serve a disproportionately White population, highlighting racial and socioeconomic gaps in healthcare reimbursement models.

Explore how a new cardio kidney screening workflow boosts urine testing efficiency, narrowing gaps in metabolic health and…

Medicare’s 2.5% dermatology reimbursement increase for 2026 falls short, leaving clinics struggling with rising costs and denied user…

Dermatologists use advanced atopic dermatitis treatments but lack predictive biomarkers for precise therapy selection.

Using insulin pump with Control-IQ technology improves glycemic status in type 2 diabetes patients with multiple daily injections,…

Health plans are blocking users from content. Learn how new Medicare changes impact formulary access and patient care.

HIV/AIDS relief efforts disrupted, affecting vulnerable populations with HIV infection, according to PEPFAR findings and survey results.